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Abstracts / Urological Science 26 (2015) S36eS49 S4710mm<IPP). All patients underwent surgical intervention with anterior
approach of prostatectomy and the continence component such as pubo-
prostatic ligament and arcus tendineus were preserved. Posterior recon-
struction of the rhabdomyosphincter was also performed. Continence was
deﬁned as no pad use or only one safety pad per day and assessed at 1, 3
and 12 months postoperatively. The correlation between the intravesical
prostatic protruding and postoperative continence was examed.
Results: The overall continence rate at 1, 3 and 12month was 69.2%, 91.33%
and 95.5%. Among the three groups, there is signiﬁcant difference in 1
month, 3 month and 12 month continence rate (IPP < 5mm: 82.5%, 96.3%,
97.7%; 5mm < IPP < 10mm: 61.9%, 89.4%, 94.4%; 10mm < IPP: 30%, 75.6%,
88.9%, p < 0.001). At one month, 415 patients achieved continence but 195
patients still incontinence and the length of IPP among the two groups
were 4.43 ± 3.74 mm and 8.69 ± 6.63mm, p < 0.001. Respectively, at the 3
month and 12 month, 548 and 573 patients achieved continence and the
IPP length among continence and incontinence groupwere 5.29 ± 4.56mm
vs. 10.50 ± 8.32mm and 5.55 ± 4.93 vs. 9.88 ± 8.37, there is also statistical
signiﬁcance.
Conclusions: To our result, the intravesical prostatic protrusion have
negative inﬂuence in continence of patients received robotic assisted
radical prostatectomy. The patient with less protruding prostate may
achieve early continence after operation and the postoperative inconti-
nence rate was markedly higher in patient with more protruding prostate.
MP5-2.
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HUMAN BLADDER CANCER CELLS WITH THE ANTIFUNGAL DRUG
MICONAZOLE
Sheau-Yun Yuan 1,3, Shian-Shiang Wang 1, Kan-Jen Tsai 2, Ming-Yuh
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Purpose: Miconazole (MIC) is an imidazole antifungal agent that is
commonly applied topically to the skin or mucous membranes to improve
fungal infections. Recent studies have demonstrated that MIC exhibits
anti-tumor effects on human colon cancers and leukemia. The aim of this
study was to determine the effects of MIC on the growth inhibition and
apoptosis of human bladder cancer cells.
Materials and methods: Human bladder cancer cell lines (T24 and TSGH-
8301) were used in this study. The T24 and TSGH-8301 cells were treated
with various concentrations (6, 12, 25, 50 and 100 mM) of MIC for 24 h each.
Cell viability was determined by MTT assay. The apoptosis mechanismwas
detected by sub-G1 population, DNA fragmentation and reactive oxygen
species (ROS) generation, and the mitochondrial membrane potentials
were evaluated by ﬂow cytometry. SDS-PAGE/Western blot assay was used
to detect apoptotic proteins (PARP, caspase-3/-8/-9), Bcl-2 family proteins
and cell-cycle-regulated proteins.
Results: The study showed that MIC elicited cytotoxic effects on human
T24 and TSGH-8301 bladder cancer cells in a dose- and time-dependent
manner with IC50 ~48.3 ± 0.35 mM and 47.8 ± 0.27 mM, respectively, as
determined by MTT assay. MIC increased the sub-G1 population, DNA
fragmentation formation, activation of caspase-3/-8/-9 and cleavage of
poly (ADPribose) polymerase (PARP), and provoked apoptosis in both
bladder cancer cell lines. Western blot analysis revealed increases of p21
and p27 protein levels, along with decreases of Cyclin E1, CDK2 and CDK4
expressed in MIC-treated T24 and TSGH-8301 cells, which is related to the
G0/G1 phase of the cell cycle. Meanwhile, there was an induced increase of
cleaved Bax proteins and a decrease of Bcl-2 proteins, up-regulation of the
DR5 death receptor and ROS generation subsequent to reduced mito-
chondrial membrane potential at higher concentrations (>50 mM) of MIC
for 24 h, in both the T24 and the TSGH-8301 bladder cancer cells.
Conclusions: These results indicate that MIC triggered apoptosis via G0/
G1 arrest, leading to the activation of the TRAIL death receptor, then
activation of caspase-3/-8/-9 and the ROS-dependent mitochondrial
pathway in human bladder cancer cells. This suggests that MIC may be a
potential anti-bladder cancer agent in humans.MP5-3.
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Purpose: Several studies explored the prognostic values of HER2 expres-
sion in upper tract urothelial carcinoma (UTUC), but the results remain not
consistent.
Materials andmethods: Using published evidence, we performed ameta-
analysis to examine its clinical values in patients with UTUC. Thirty-ﬁve
articles from 679 references related to EGFR family expression assessment
in UTUC were reviewed and there were 7 papers ﬁt for analyses. The es-
timates included the odds ratio (OR), distribution related to stage and
grade, hazard ratios (HR), and 95% conﬁdence intervals (CI) from survival
analyses of intravesical recurrence, progression and overall survival.
Results: The pooled results showed that HER2 expression is signiﬁcantly
associated with higher stage, but not with tumor grade in patients with
UTUC (OR, 2.05; 95% CI, 1.15-3.68; p ¼ 0.016 and OR, 4.73; 95% CI,
0.80e27.8; p ¼ 0.086, respectively). Also, the pooled survival analyses
demonstrated that HER2 expression yielded a worse recurrence-free sur-
vival in UTUC patients (HR, 4.32; 95% CI, 2.17e8.60; p < 0.0001). However,
there is lack of statistical signiﬁcance in term of progression-free survival
an overall survival (HR, 2.08; 95%CI, 0.46e9.32; p ¼ 0.339 and HR, 1.06;
95% CI, 0.48e2.37; p ¼ 0.879, respectively).
Conclusion: The relevant studies existed heterogeneous and were limited.
Our analysis suggests that HER2 expression plays an important role in
subsequent recurrence in the urinary bladder after primary treatment for
UTUC.
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Purpose: Bladder cancer is a common human malignancy and exhibits a
life-long risk of disease recurrence and progression. It is continuing to
search some simple, innovative biomarker to monitor the disease status
in order to diminish the suffering during cystoscopic follow-up. The
metabolite of tryptophan after indoleamine 2,3-dioxygenase (IDO)
digestion, 3-Hydroxyanthranilic acid (3-HAA) is conventionally thought
to be a potential biomarker for bladder cancer occurrence. The aim to
study is to investigate the diagnostic potential of an integrated a 3-HAA-
based biosensor for urothelial carcinoma of the upper tract and urinary
bladder.
Materials and methods: Human urothelial cancer cell lines and human
urothelial carcinoma tissues as well as adjacent benign tissues were
available for exploring IDO expression, including western blotting and
immunohistochemical staining. Patients who received urological surgery
were enrolled for urine 3-HAA testing using an integrating biosensor for 3-
HAA. Some of urine specimens were investigated with high performance
liquid chromatography (HPLC) assay.
Results: From western blotting assays, eight human urothelial carcinoma
cell lines exhibited more IDO expression than the immortalized cell SV-
HUC. Both of urothelial carcinoma of urinary bladder and upper urinary
tract exhibited more IDO immunoreactivity than those of the adjacent
